NN

Namit Nischal

Active Director Director DIN 08661583
DIN 08661583 First appointment Jul 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Namit Nischal

Data last updated:

Namit Nischal is a Director at Betamed Exim Private Limited (since 2020). The company operates in Healthcare. Betamed Exim Private Limited reported revenue of ₹91.9 Lakh (FY 2024).

DIN 08661583
Primary Designation Director
Industry Healthcare
First Appointment 10 Jul 2020
Oldest Company Age 9 yrs
Largest company Betamed Exim Private Limited · ₹91.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Betamed Exim Private Limited U33309DL2017PTC323485
Director10 Jul 20202017₹91.9 Lakh (FY 2024)Active

Board colleagues of Namit Nischal

Directorship timeline

Open interactive timeline →
Betamed Exim Private Limited
Premium access

Shareholding and investment profile for Namit Nischal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Namit Nischal

Namit Nischal currently holds 1 directorship: Betamed Exim Private Limited (Director, since 10 Jul 2020, revenue ₹91.9 Lakh (FY 2024)).

Namit Nischal was first appointed on 10 Jul 2020 as Director at Betamed Exim Private Limited.

The current boards of Namit Nischal's companies include Kunal Nischal (Betamed Exim Private Limited), Minakashi Nischal (Betamed Exim Private Limited), Sanjeev Nischal (Betamed Exim Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available